Cargando…

Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies

Treatment of hematological malignant disorders has been improved over the last years, but high relapse rate mainly attributable to the presence of minimal residual disease still persists. Therefore, it is of great interest to explore novel therapeutic strategies to obtain long-term remission. Immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gismondi, Angela, Stabile, Helena, Nisti, Paolo, Santoni, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633523/ https://www.ncbi.nlm.nih.gov/pubmed/26594216 http://dx.doi.org/10.3389/fimmu.2015.00567

Ejemplares similares

Role of Distinct Natural Killer Cell Subsets in Anticancer Response
por: Stabile, Helena, et al.
Publicado: (2017)

Natural Killer Cells Modulation in Hematological Malignancies
por: Baier, Céline, et al.
Publicado: (2013)

NK Cell Reconstitution in Paediatric Leukemic Patients after T-Cell-Depleted HLA-Haploidentical Haematopoietic Stem Cell Transplantation Followed by the Reinfusion of iCasp9-Modified Donor T Cells
por: Stabile, Helena, et al.
Publicado: (2019)

Key Role of the CD56(low)CD16(low) Natural Killer Cell Subset in the Recognition and Killing of Multiple Myeloma Cells
por: Vulpis, Elisabetta, et al.
Publicado: (2018)

Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies
por: Pittari, Gianfranco, et al.
Publicado: (2015)

Mechanosensation and Mechanotransduction in Natural Killer Cells
por: Santoni, Giorgio, et al.
Publicado: (2021)

Multiple Levels of Chemokine Receptor Regulation in the Control of Mouse Natural Killer Cell Development
por: Bernardini, Giovanni, et al.
Publicado: (2014)

Kctd9 Deficiency Impairs Natural Killer Cell Development and Effector Function
por: Zhang, Xiaoping, et al.
Publicado: (2019)

NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells
por: Foltz, Jennifer A., et al.
Publicado: (2016)

CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells
por: Kurioka, Ayako, et al.
Publicado: (2018)

GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells
por: Kosta, Andrea, et al.
Publicado: (2022)

Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells
por: Ferlazzo, Guido, et al.
Publicado: (2014)

Invariant Natural Killer T Cell Subsets—More Than Just Developmental Intermediates
por: Krovi, S. Harsha, et al.
Publicado: (2018)

Specialized Roles of Human Natural Killer Cell Subsets in Kidney Transplant Rejection
por: Kildey, Katrina, et al.
Publicado: (2019)

Dynamic Changes in Natural Killer Cell Subset Frequencies in the Absence of Cytomegalovirus Infection
por: Gyurova, Ivayla E., et al.
Publicado: (2019)

Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function
por: Carreira-Santos, Sofía, et al.
Publicado: (2023)

Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
por: Zingoni, Alessandra, et al.
Publicado: (2017)

Natural killer cells in non-hematopoietic malignancies
por: Desbois, Mélanie, et al.
Publicado: (2012)

Age-dependent NK cell dysfunctions in severe COVID-19 patients
por: Fionda, Cinzia, et al.
Publicado: (2022)

Cytokine-Based Generation of CD49a(+)Eomes(−/+) Natural Killer Cell Subsets
por: Ni, Xiang, et al.
Publicado: (2018)

Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies
por: Carrega, Paolo, et al.
Publicado: (2017)

Cryopreserved PM21-Particle-Expanded Natural Killer Cells Maintain Cytotoxicity and Effector Functions In Vitro and In Vivo
por: Oyer, Jeremiah L., et al.
Publicado: (2022)

Role of Natural Killer Cells in HIV-Associated Malignancies
por: Leal, Fabio E., et al.
Publicado: (2017)

Natural Killer Cells in the Malignant Niche of Multiple Myeloma
por: Venglar, Ondrej, et al.
Publicado: (2022)

Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication
por: Zhao, Di, et al.
Publicado: (2018)

Hepatitis C Virus and Human Cytomegalovirus—Natural Killer Cell Subsets in Persistent Viral Infections
por: Pollmann, Julia, et al.
Publicado: (2017)

Serpinb1a Is Dispensable for the Development and Cytokine Response of Invariant Natural Killer T Cell Subsets
por: Leborgne, Nathan G. F., et al.
Publicado: (2020)

Developmental and Functional Control of Natural Killer Cells by Cytokines
por: Wu, Yang, et al.
Publicado: (2017)

The Critical Role of IL-15–PI3K–mTOR Pathway in Natural Killer Cell Effector Functions
por: Nandagopal, Neethi, et al.
Publicado: (2014)

Histone Deacetylase 7 mediates tissue-specific autoimmunity via control of innate effector function in invariant Natural Killer T Cells
por: Kasler, Herbert G, et al.
Publicado: (2018)

Human CD56(dim)CD16(dim) Cells As an Individualized Natural Killer Cell Subset
por: Amand, Mathieu, et al.
Publicado: (2017)

Natural Killer Cell-Mediated Cellular Therapy of Hematological Malignancies
por: Sahin, Ugur, et al.
Publicado: (2019)

Differential chemotactic receptor requirements for NK cell subset trafficking into bone marrow
por: Bernardini, Giovanni, et al.
Publicado: (2013)

Effector T Helper Cell Subsets in Inflammatory Bowel Diseases
por: Imam, Tanbeena, et al.
Publicado: (2018)

Vaccinating for natural killer cell effector functions
por: Wagstaffe, Helen R, et al.
Publicado: (2018)

Defining a novel subset of CD1d‐dependent type II natural killer T cells using natural killer cell‐associated markers
por: Singh, Avadhesh Kumar, et al.
Publicado: (2019)

Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
por: Uppendahl, Locke D., et al.
Publicado: (2018)

IL-10 Enhances Human Natural Killer Cell Effector Functions via Metabolic Reprogramming Regulated by mTORC1 Signaling
por: Wang, Zixi, et al.
Publicado: (2021)

Azithromycin Differentially Alters TCR-Activated Helper T Cell Subset Phenotype and Effector Function
por: Ansari, Abdul Wahid, et al.
Publicado: (2020)

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future
por: Lamb, Margaret G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dq7h5jjslk3u3vriis8ojg1cf3